Edition:
United States

Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

17.33USD
7 Dec 2016
Change (% chg)

-- (--)
Prev Close
$17.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
246,186
52-wk High
$20.59
52-wk Low
$12.45

AMRI.O

Chart for AMRI.O

About

Albany Molecular Research, Inc. is a global contract research and manufacturing company. The Company provides drug discovery, development, and manufacturing services. The Company operates through three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $743.30
Shares Outstanding(Mil.): 42.89
Dividend: --
Yield (%): --

Financials

  AMRI.O Industry Sector
P/E (TTM): -- 42.12 30.77
EPS (TTM): -1.41 -- --
ROI: -5.90 -0.81 15.23
ROE: -16.90 -1.52 16.56

BRIEF-AMRI announces API agreement supply with Shire

* Has entered into a multi-year supply agreement for an undisclosed product with shire us manufacturing Source text for Eikon: Further company coverage:

Nov 29 2016

BRIEF-Amri Q3 non-gaap EPS $0.17

* Albany molecular research inc sees full year 2016 capital expenditures of approximately $48 million

Nov 08 2016

BRIEF-Albany Molecular files for secondary offering of 7 million shares of its common stock

* Albany Molecular files for secondary offering of 7 million shares of its common stock - SEC filing Source text for Eikon: Further company coverage:

Sep 23 2016

Earnings vs. Estimates